Syndicated Research Studies

The pulse oximeter market is no longer simply a story about fingertip devices and the pandemic-era rush to monitor blood oxygen levels at home. Valued at USD 3.9 billion in 2025, the market is projected to reach USD 6.1 billion by 2033, advancing at a 5.4% CAGR. At first glance, that looks like a relatively steady growth story. But beneath the headline numbers, the pulse oximeter market is undergoing meaningful changes in technology, healthcare delivery, product design, and regulatory expectations. The pandemic certainly created an extraordinary short-term demand surge. However, the factors supporting long-term expansion are much broader. From remote patient monitoring and wearable devices to improved accuracy across diverse skin tones, several assumptions about pulse oximeters no longer hold up. Download a free sample report or claim your copy of this full market intelligence report Here are six myths the latest market data challenges. Myth 1: The Pulse Oximeter Boom Was a COVID...

Pulse Oximeter Industry Overview The global pulse oximeter market size was valued at USD 2.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.4% from 2021 to 2028. Rising awareness regarding applications of pulse oximeters in COVID-19 management and the increasing prevalence of target diseases is expected to drive the growth of the market. Availability of new products and high unmet needs in developing and least-developed economies are expected to boost market growth over the forecast period. Around 43 states in the U.S. have made pulse oximetry mandatory for newborn screening and is gaining popularity in other countries due to applications in the detection of Congenital Heart Defects (CHD) and other heart and respiratory conditions. Gather more insights about the market drivers, restrains and growth of the Global Pulse Oximeter Market The growing prevalence of target diseases such as asthma, hyperlipidemia, hypertension, diabetes, is...